menu search

NPCE / NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the third quarter of 2023 after market close on Monday November 6, 2023. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Read More
Posted: Oct 16 2023, 17:01
Author Name: GlobeNewsWire
Views: 092084

NPCE News  

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

By GlobeNewsWire
October 16, 2023

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transfor more_horizontal

NeuroPace: A Speculative Epilepsy Play

By Seeking Alpha
September 5, 2023

NeuroPace: A Speculative Epilepsy Play

NeuroPace aims to improve the lives of epilepsy patients with its remote monitoring system. The company's RNS system offers personalized and real-time more_horizontal

NeuroPace, Inc. (NPCE) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 11, 2023

NeuroPace, Inc. (NPCE) Q2 2023 Earnings Call Transcript

NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Irina Ridley - Chief Legal Officer and more_horizontal

NeuroPace, Inc. (NPCE) CEO Michael Favet on Q1 2023 Results - Earnings Call Transcript

By Seeking Alpha
May 7, 2023

NeuroPace, Inc. (NPCE) CEO Michael Favet on Q1 2023 Results - Earnings Call Transcript

NeuroPace, Inc. (NASDAQ:NPCE ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group Michael Fave more_horizontal

NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference

By GlobeNewsWire
April 3, 2023

NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference

MOUNTAIN VIEW, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transfo more_horizontal

NeuroPace, Inc. (NPCE) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 2, 2023

NeuroPace, Inc. (NPCE) Q4 2022 Earnings Call Transcript

NeuroPace, Inc. (NASDAQ:NPCE ) Q4 2022 Results Conference Call March 2, 2023 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group Michael Fav more_horizontal

NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

By GlobeNewsWire
December 21, 2022

NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transfor more_horizontal

Accelmed Partners Takes Activist Position in NPCE / Neuropace After Q3 Results

By 24/7 Wall Street
November 23, 2022


Search within

Pages Search Results: